PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy

Cancer immunotherapy has been revolutionised by drugs that enhance the ability of the immune system to detect and fight tumors. Immune checkpoint therapies that target the programmed death-1 receptor (PD-1), or its ligand (PD-L1) have shown unprecedented rates of durable clinical responses in patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Rolfes, Verena, Idel, Christian, Pries, Ralph, Plötze-Martin, Kirstin, Habermann, Jens, Gemoll, Timo, Bohnet, Sabine, Latz, Eicke, Ribbat-Idel, Julika, Franklin, Bernardo S., Wollenberg, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007942/
https://ncbi.nlm.nih.gov/pubmed/29937998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25446
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados